Literature DB >> 17859363

Results of Treatment of Patients with Hypertension by Total Thoracic and Partial to Total Lumbar Sympathectomy, Splanchnicectomy and Celiac Ganglionectomy.

K S Grimson, E S Orgain, B Anderson, R A Broome, F H Longino.   

Abstract

Entities:  

Year:  1949        PMID： 17859363      PMCID： PMC1514176     

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  5 in total

1.  Factors Limiting Surgery for Essential Hypertension.

Authors:  P Heinbecker
Journal:  Ann Surg       Date:  1947-10       Impact factor: 12.969

2.  The Etiology and Treatment of Polycythemia Rubra Vera : Observations Based upon Studies of Body Fluid Changes in Dogs Subjected to Proprioceptor Depressor Neurotomy and Extensive Sympathectomy, Including the Case Report of a Man with Polycythemia Rubra Vera Treated by Extensive Para-Vertebral Sympathectomy.

Authors:  P W Schafer
Journal:  Ann Surg       Date:  1945-12       Impact factor: 12.969

3.  Blood Pressure of Renal and of Early and Late Neurogenic Hypertension Dogs after Low Cervical Cord Section.

Authors:  K S Grimson
Journal:  Ann Surg       Date:  1945-12       Impact factor: 12.969

4.  TOTAL THORACIC AND PARTIAL TO TOTAL LUMBAR SYMPATHECTOMY AND CELIAC GANGLIONECTOMY IN THE TREATMENT OF HYPERTENSION.

Authors:  K S Grimson
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

5.  ON THE OCCURRENCE, SITES AND MODES OF ORIGIN AND DESTRUCTION, OF PRINCIPLES AFFECTING THE COMPENSATORY VASCULAR MECHANISMS IN EXPERIMENTAL SHOCK.

Authors:  E Shorr; B W Zweifach; R F Furchgott
Journal:  Science       Date:  1945-11-16       Impact factor: 47.728
  5 in total
  15 in total

1.  The sympathetic nerve supply of the upper limb in relation to sympathectomy.

Authors:  H A HAXTON
Journal:  Ann R Coll Surg Engl       Date:  1954-04       Impact factor: 1.891

2.  Total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy for hypertension.

Authors:  K S GRIMSON; E S ORGAIN; B ANDERSON; G J D'ANGELO
Journal:  Ann Surg       Date:  1953-10       Impact factor: 12.969

3.  Studies on autonomic blockade. I. Comparison between the effects of tetraethylammonium chloride (TEAC) and high selective spinal anesthesia on blood pressure of normal and toxemic pregnancy.

Authors:  N S ASSALI; H PRYSTOWSKY
Journal:  J Clin Invest       Date:  1950-10       Impact factor: 14.808

Review 4.  Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Authors:  Vinay Gulati; William B White
Journal:  J Am Soc Hypertens       Date:  2013-08-15

Review 5.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

6.  Can physiology zap therapeutic sweet spots in hypertension?

Authors:  Michael J Joyner
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

Review 7.  Selective vs. Global Renal Denervation: a Case for Less Is More.

Authors:  Marat Fudim; Asher A Sobotka; Yue-Hui Yin; Joanne W Wang; Howard Levin; Murray Esler; Jie Wang; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 8.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 9.  Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Authors:  Matthew G Denker; Debbie L Cohen; Raymond R Townsend
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

10.  [Renal denervation: current state and future perspectives].

Authors:  K Kara; H Bruck; P Kahlert; B Plicht; A A Mahabadi; T Konorza; R Erbel
Journal:  Herz       Date:  2012-11       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.